Combretastatin A4 Nanodrug‐Induced MMP9 Amplification Boosts Tumor‐Selective Release of Doxorubicin Prodrug-Reference-Cited by-同舟云学术

Combretastatin A4 Nanodrug‐Induced MMP9 Amplification Boosts Tumor‐Selective Release of Doxorubicin Prodrug

Published:2019-09-24 Issue:44 Volume:31 Page:1904278
ISSN:0935-9648
Container-title:Advanced Materials
language:en
Short-container-title:Adv. Mater.

Author:

Jiang Jian¹²,Shen Na¹,Ci Tianyuan³⁴,Tang Zhaohui¹²,Gu Zhen³⁴^ORCID,Li Gao¹²,Chen Xuesi¹²

Affiliation:

1. Key Laboratory of Polymer EcomaterialsJilin Biomedical Polymers Engineering LaboratoryChangchun Institute of Applied ChemistryChinese Academy of Sciences Changchun 130022 P. R. China

2. School of Applied Chemistry and EngineeringUniversity of Science and Technology of China Hefei 230026 P. R. China

3. Department of BioengineeringUniversity of California Los Angeles CA 90095 USA

4. California NanoSystems Institute (CNSI)Jonsson Comprehensive Cancer CenterCenter for Minimally Invasive TherapeuticsUniversity of California Los Angeles CA 90095 USA

Funder

National Natural Science Foundation of China

Ministry of Science and Technology of the People's Republic of China

People's Government of Jilin Province

Publisher

Wiley

Subject

Mechanical Engineering,Mechanics of Materials,General Materials Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adma.201904278

Reference42 articles.

1. Fluorogenic reaction-based prodrug conjugates as targeted cancer theranostics